Profil
Douglas Greene served as the Executive Vice President of Research and Development at Ikaria, Inc. He also worked as the Chief Medical Officer at Sanofi-Aventis Pharmaceuticals for a brief period in 2009.
Ehemalige bekannte Positionen von Douglas Greene
| Unternehmen | Position | Ende |
|---|---|---|
| Sanofi-Aventis Pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
| IKARIA, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
| Sanofi-Aventis Pharmaceuticals |
